●New Issue Published: Volume 16, Issue 1 (Jan-Feb 2026)●Call for Papers: Volume 16, Issue 2 — Submit by March-April 2026●Open Access — All articles freely available worldwide●New Issue Published: Volume 16, Issue 1 (Jan-Feb 2026)●Call for Papers: Volume 16, Issue 2 — Submit by March-April 2026●Open Access — All articles freely available worldwide
Journal Official Logo
International Journal ofAyurvedic and Herbal Medicine
arrow_backBack to Issue
arrow_backPrevious Article

Bioactive Compounds from Ayurvedic, Traditional Chinese, and African Medicinal Systems: Chemical Characterisation, Pharmacological Activities, and Implications for Modern Drug Discovery

Published:04 Mar 2026
visibility9 Viewsdownload5 Downloads
Asha Nandabaram1*, Manasa Baligari1, Lakshmi Manisha Rajaputana1, Bhavani Bachu1, Muvvala Sudhakar1

1 Department of Pharmacology, Malla Reddy College of Pharmacy, Affiliated to Osmania University, Hyderabad, India.

Corresponding Author:Asha Nandabaram

picture_as_pdfDownload link10.47191/ijahm/v16i2.01

subjectAbstract

Traditional medical systems such as Ayurveda, Traditional Chinese Medicine (TCM), and African Traditional Medicine (ATM) represent rich reservoirs of therapeutic knowledge developed over thousands of years. These systems primarily rely on medicinal plants containing diverse bioactive compounds responsible for their pharmacological effects. With growing interest in natural products for safer and multi-target therapies, scientific validation of traditional medicines has become increasingly important. This review critically examines the major bioactive compounds reported in Ayurvedic, Chinese, and African traditional medicines, focusing on their chemical nature, pharmacological activities, and molecular mechanisms of action. Emphasis is placed on neuroprotective, anti-inflammatory, antioxidant, antimicrobial, and metabolic regulatory activities, along with their relevance to modern drug discovery. Challenges related to standardization, safety, and clinical validation are discussed, and future research directions are proposed. Integrating traditional knowledge with modern pharmacology may accelerate the development of novel therapeutic agents.

sellKeywords

Traditional medicineBioactive compoundsAyurvedaTraditional Chinese MedicineAfrican Traditional MedicinePhytochemicalsDrug discoveryModern validation

format_list_numberedReferences

  1. Newman DJ, Cragg GM. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J Nat Prod. 2020; 83(3): 770-803.
  2. Atanasov AG, Zotchev SB, Dirsch VM, Supuran CT. Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov. 2021; 20(3): 200-216.
  3. Cragg GM, Newman DJ. Natural products: a continuing source of novel drug leads. Biochim Biophys Acta. 2013; 1830(6): 3670-3695.
  4. Harvey AL, Edrada-Ebel R, Quinn RJ. The re-emergence of natural products for drug discovery in the genomics era. Nat Rev Drug Discov. 2015; 14(2): 111-129.
  5. Butler MS, Robertson AAB, Cooper MA. Natural product and natural product derived drugs in clinical trials. Nat Prod Rep. 2014; 31(11): 1612-1661.
  6. Patwardhan B, Vaidya ADB, Chorghade M. Ayurveda and natural products drug discovery. Curr Sci. 2004; 86(6): 789-799.
  7. Patwardhan B, Mashelkar RA. Traditional medicine-inspired approaches to drug discovery: can Ayurveda show the way forward? Drug Discov Today. 2009; 14(15-16): 804-811.
  8. Vaidya ADB, Devasagayam TPA. Current status of herbal drugs in India: an overview. J Clin Biochem Nutr. 2007; 41(1): 1-11.
  9. Parasuraman S, Thing GS, Dhanaraj SA. Polyherbal formulation: concept of Ayurveda. Pharmacogn Rev. 2014; 8(16): 73- 80.
  10. Sharma PV. Dravyaguna Vijnana (Materia Medica of Ayurveda). Varanasi: Chaukhambha Bharati Academy; 2001.
  11. Mukherjee PK. Quality Control and Evaluation of Herbal Drugs. Amsterdam: Elsevier; 2019.
  12. Williamson EM. Synergy and other interactions in phytomedicines. Phytomedicine. 2001; 8(5): 401-409.
  13. Heinrich M, et al. Ethnopharmacology and drug discovery: a new era. Nat Rev Drug Discov. 2020; 19(7): 461-462.
  14. Li S, Zhang B. Traditional Chinese medicine network pharmacology: theory, methodology and application. Chin J Nat Med. 2013; 11(2): 110-120.
  15. Hopkins AL. Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol. 2008; 4(11): 682-690.
  16. Wang X, Zhang A, Sun H, Wang P, Wang X. Systems pharmacology for traditional Chinese medicine. Trends Pharmacol Sci. 2011; 32(12): 754-758.
  17. Zhao J, Jiang P, Zhang W. Molecular networks for the study of TCM pharmacology. Brief Bioinform. 2010; 11(4): 417-430.
  18. Chen X, et al. Database and bioinformatics studies for traditional Chinese medicine research. Chin Med. 2016; 11: 45.
  19. Zhang A, Sun H, Wang X. Mass spectrometry-driven drug discovery from traditional Chinese medicine. J Pharm Biomed Anal. 2018; 147: 500-507.
  20. Xu J, Yang Y. Traditional Chinese medicine in the Chinese health care system. Health Policy. 2013; 90(2-3): 133-139.
  21. Mahomoodally MF. Traditional medicines in Africa: an appraisal of ten potent African medicinal plants. Evid Based Complement Alternat Med. 2013; 2013: 617459.
  22. Van Wyk BE, Wink M. Medicinal Plants of the World. Pretoria: Briza Publications; 2004.
  23. Gurib-Fakim A. Medicinal plants: traditions of yesterday and drugs of tomorrow. Mol Aspects Med. 2006; 27(1): 1-93.
  24. Hostettmann K, Marston A, Ndjoko K, Wolfender JL. The potential of African plants as a source of drugs. Chimia. 2000; 54(11): 652-657.
  25. Cordell GA. Natural products in drug discovery — creating a new vision. Phytochem Rev. 2012; 11(2-3): 141-157.
  26. Rates SMK. Plants as source of drugs. Toxicon. 2001; 39(5): 603-613.
  27. World Health Organization. WHO Traditional Medicine Strategy 2014–2023. Geneva: WHO; 2013.
  28. World Health Organization. Guidelines for the Assessment of Herbal Medicines. Geneva: WHO; 1991.
  29. Harborne JB. Phytochemical Methods: A Guide to Modern Techniques of Plant Analysis. 3rd ed. London: Springer; 1998.
  30. Trease GE, Evans WC. Pharmacognosy. 16th ed. London: Elsevier; 2009.
  31. Bruneton J. Pharmacognosy, Phytochemistry, Medicinal Plants. 2nd ed. Paris: Lavoisier; 1999.
  32. Wink M. Modes of action of herbal medicines and plant secondary metabolites. Medicines (Basel). 2015; 2(3): 251-286.
  33. Cushnie TPT, Lamb AJ. Antimicrobial activity of flavonoids. Int J Antimicrob Agents. 2005; 26(5): 343-356.
  34. Osbourn AE, Goss RJM, Field RA. The saponins – polar isoprenoids with important biological activities. Nat Prod Rep. 2011; 28(7): 1261-1268.
  35. Crozier A, Jaganath IB, Clifford MN. Dietary phenolics: chemistry, bioavailability and effects on health. Nat Prod Rep. 2009; 26(8): 1001-1043.
  36. Efferth T, Koch E. Complex interactions between phytochemicals: the multi-target therapeutic concept of phytotherapy. Phytomedicine. 2011; 18(1): 74-82.
  37. Mosihuzzaman M, Choudhary MI. Protocols on safety, efficacy, standardization, and documentation of herbal medicine. Phytother Res. 2008; 22(4): 427-433.
  38. Sahoo N, Manchikanti P, Dey S. Herbal drugs: standards and regulation. Fitoterapia. 2010; 81(6): 462-471.
  39. European Medicines Agency. Guideline on Quality of Herbal Medicinal Products/Traditional Herbal Medicinal Products. London: EMA; 2011.
  40. Upton R, et al. American Herbal Pharmacopoeia. Scotts Valley: American Herbal Pharmacopoeia; 2011.
  41. Ekins S, Puhl AC, Zorn KM, et al. Exploiting machine learning for end-to-end drug discovery and development. Nat Mater. 2019; 18(5): 435-441.
  42. Walters WP, Murcko MA. Assessing the impact of generative AI on medicinal chemistry. Nat Biotechnol. 2020; 38(2): 143-145.
  43. Goh GB, Hodas NO, Vishnu A. Deep learning for computational chemistry. J Comput Chem. 2017; 38(16): 1291-1307.
  44. Luo Y, et al. A network integration approach for drug discovery from herbal medicine. Brief Bioinform. 2020; 21(4): 1363-1375.
  45. Ma C, et al. Metabolomics in the study of traditional Chinese medicine. Phytochem Anal. 2015; 26(2): 94-105.
  46. Nandabaram A, Mayasa V. Interactions of Pearl Millet Diet on Pharmacodynamics and Pharmacokinetics of Gliclazide in Healthy Rats. Indian J Pharm Sci. 2024;86(4):1571-1578.
  47. Nandabaram A, Nelson VK, Mayasa V. Assessment of Possible Food-Drug Interactions of Pearl Millet Diet on Gliclazide in Diabetic Rats. Texila Int J Public Health. 2025;13(1). doi: 10.21522/TIJPH.2013.13.01.Art058
  48. Asha N, Vinyas M. Exploring the Possible Food-Drug Interactions of Foxtail Millet Diet on Gliclazide in Healthy Rats. J Chem Health Risks. 2024;14(3):216-223.

How to Cite

Nandabaram, A., Baligari, M., Rajaputana, L. M., Bachu, B., & Sudhakar, M. (2026). Bioactive Compounds from Ayurvedic, Traditional Chinese, and African Medicinal Systems: Chemical Characterisation, Pharmacological Activities, and Implications for Modern Drug Discovery. International Journal of Ayurvedic and Herbal Medicine, 16(2). https://doi.org/10.47191/ijahm/v16i2.01

APA

American Psychological Association Style

arrow_back
Previous ArticleA Review on Antifungal Potential of Hibiscus rosa-sinensis and Bougainvillea spectabilis